Background/Purpose: This trial aimed to compare the efficacy and safety of methotrexate (MTX) vs. tocilizumab (TCZ), in combination with glucocorticoid (GC), in patients with giant cell arteritis (GCA). Methods: METOGiA is an open label randomized controlled multicenter trial, with a non-inferiority design. Results from the first 78-week period are reported here, in which patients received … Continue reading MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial.